• GTP Solution (100 mM): From IVT to Assay Design

  2026-09-17

  Explore how GTP Solution supports nucleotide-sensitive workflows, from in vitro transcription to signal transduction research. This article uses the p21 mRNA–LNP bladder cancer study to explain reagent selection, assay controls, and translational limitations beyond routine protocol guidance.

• Amyloid β-Peptide (1-42) Workflow Guide

  2026-09-17

  Build more reproducible Aβ42 peptide experiments by controlling solubility, aggregation state, and assay timing from the first dilution. This guide connects neurotoxicity, neuronal ion channel modulation, and ratiometric fibril imaging into a practical Alzheimer’s disease research workflow.

• Forsythoside E for PKM2 Macrophage Workflows

  2026-09-16

  Forsythoside E converts a PKM2-centered mechanism into a practical workflow for measuring macrophage metabolism, STAT3 signaling, and M2 polarization. Its defined binding, concentration, solubility, and dosing data support mechanism-led studies of sepsis-induced liver injury while helping researchers distinguish target engagement from nonspecific anti-inflammatory effects.

• Repaglinide: Mechanism, Evidence, and AML Context

  2026-09-16

  Repaglinide is a short-acting oral insulin secretagogue that lowers blood glucose by stimulating pancreatic beta-cell insulin release. The cited AML study describes an ATG4B–PRMT1–MRE11 DNA-repair mechanism, but it does not establish repaglinide as an ATG4B inhibitor or leukemia treatment.

• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-09-15

  Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Their inhibitor studies identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated entry, as key mechanisms that can guide more rational ocular drug-delivery design.

• Filipin III for Macrophage Cholesterol Mapping

  2026-09-15

  Filipin III converts membrane cholesterol chemistry into spatial and ultrastructural readouts for macrophage and vesicle experiments. This guide connects cholesterol imaging with the 25-hydroxycholesterol–CH25H pathway described in a recent Immunity study while emphasizing controls, workflow design, and interpretation limits.

• Taihangia rupestris: UPLC-MS/MS and Bioactivity

  2026-09-14

  A 2026 RSC Advances study combined UPLC-MS/MS, multivariate analysis, complementary antioxidant assays, α-glucosidase inhibition, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest flavonoid- and phenolic-associated profile and activity, supporting cultivation as a conservation-compatible source for natural product antioxidant evaluation and antidiabetic lead discovery.

• Chemistry of Silybin: Structure, Separation, and Derivatives

  2026-09-14

  The reference review establishes a chemical framework for silybin by integrating its historical isolation, stereochemical assignment, diastereomer separation, synthesis, and derivative chemistry. Its central practical contribution is showing why defined silybin A and silybin B standards are essential for interpreting studies that otherwise use the chemically heterogeneous mixture Silymarin.

• Antimycin A4: ATP-Citrate Lyase Workflows

  2026-09-13

  Antimycin A4 combines ATP-citrate lyase inhibition with mitochondrial respiratory-chain blockade, making it useful for separating lipid-biosynthesis effects from cellular energy failure. This guide provides practical biochemical, cell-based, and troubleshooting workflows while emphasizing controls needed to interpret its dual activity.

• GOB-38 in Elizabethkingia: Function and Resistance

  2026-09-12

  The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, and shows that its hydrolytic profile spans penicillins, cephalosporins, and carbapenems. By combining recombinant expression, substrate profiling, genomic analysis, cloning, and co-culture experiments, the authors connect enzyme-level activity with broader concerns about carbapenem resistance and interspecies dissemination.

• Valemetostat (DS-3201): EZH1/2 Inhibitor Guide

  2026-09-11

  Valemetostat, also known as DS-3201, is a selective dual EZH1/2 inhibitor designed to suppress PRC2-associated EZH2 methyltransferase activity. The product dossier reports nanomolar EZH2 potency, research relevance in lymphoma models, and formulation constraints that require careful solvent and storage control.

• Nystatin (Fungicidin): Reliable Cell Assays

  2026-09-11

  Learn how Nystatin (Fungicidin), SKU B1993, can support reproducible antifungal controls and contamination-aware cell viability workflows. This scenario-based guide covers mechanism, assay compatibility, stock preparation, species-specific interpretation, and practical vendor selection.

• Cisapride (R 51619) in Cardiac Safety Assays

  2026-09-10

  Cisapride (R 51619) connects 5-HT4 receptor signaling pathway studies with hERG channel inhibition and high-content cardiotoxicity workflows. This guide shows how to use the compound in iPSC-cardiomyocyte assays, orthogonal electrophysiology, and troubleshooting-focused screening designs.

• NHS-Biotin as a Readout for Protein Assemblies

  2026-09-10

  NHS-Biotin is more than a general protein-labeling reagent: it can provide a controlled analytical readout for engineered assemblies. This guide explains how amine-reactive biotinylation complements peptidisc-assisted nanobody multimerization without confusing labeling with the mechanism of assembly.

• PDAC Organoid–Fibroblast Models of Chemoresistance

  2026-09-09

  Schuth et al. developed patient-matched three-dimensional co-cultures that combine pancreatic ductal adenocarcinoma organoids with cancer-associated fibroblasts to model stromal effects on drug response. The system linked fibroblast-associated protection from chemotherapy with inflammatory CAF states, epithelial-to-mesenchymal transition programs, and candidate receptor–ligand interactions, supporting more physiologically relevant personalized drug testing.

8454 records 1/564 page Next 12345 下5页 Last page